Skip to main content

Blog entry by Julio Erwin

What's The Current Job Market For ADHD Medication Pregnancy Professionals?

What's The Current Job Market For ADHD Medication Pregnancy Professionals?

ADHD Medication During Pregnancy and Breastfeeding

general-medical-council-logo.pngThe choice of whether to stop or continue ADHD medication during pregnancy and breastfeeding is challenging for women with the condition. Little data exists about how long-term exposure to these medications may affect the fetus.

iampsychiatry-logo-wide.pngA recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication must consider the benefits of taking it versus the dangers for the foetus. Doctors don't have the necessary data to make unequivocal recommendations, but they can provide information about benefits and risks that can assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during their early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was correct and to reduce any bias.

The study of the researchers was not without its limitations. The most important issue was that they were unable to separate the effects of the medication from those of the disorder that is underlying. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups exposed were due to medication use, or if they were affected by comorbidities. Additionally, the researchers did not examine the long-term effects of offspring on their parents.

The study did show that babies whose mothers had taken Adhd Medication Pregnancy medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those who whose mothers did not take any medication or had cut back on their medications prior to or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission was not found to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during early pregnancy could be offset by the higher benefit for both mother and child from continued treatment genetic testing for adhd medications the woman's condition. Physicians should discuss the issue with their patients and, when possible, assist them in developing strategies to improve their coping abilities which can reduce the impact of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are often made without clear and reliable evidence. Instead, physicians must consider their own expertise and experience, as well as the experiences of other doctors, and the research on the topic.

The issue of possible risks to infants is difficult to determine. A lot of studies on this subject are based on observational data rather than controlled research and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which could undervalue the serious teratogenic effects that can result in abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing both information on deceased and live births.

The conclusion is that while some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link, and most studies demonstrate a neutral or slightly negative impact. In the end an accurate risk-benefit analysis is required in every instance.

It can be difficult, if not impossible, for women with ADHD to stop taking their medication. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. A loss of medication may affect the ability to safely drive and to perform work-related tasks which are essential aspects of normal life for those with ADHD.

She recommends women who are unsure about whether or not to stop taking medication because of their pregnancy, consider informing family members, friends and colleagues on the condition, its effects on daily functioning, and the advantages of staying on the current treatment regimen. Educating them can also aid in ensuring that the woman feels supported in her struggle with her decision. Certain medications can pass through the placenta. If a patient decides to not take her ADHD medication while breastfeeding, it is crucial to be aware that the medication could be transferred to the infant.

Risk of Birth Defects

As the use and misuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases the concern over the possible effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Utilizing two huge data sets researchers were able analyze more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that, while the overall risk is low, first-trimester ADHD exposure to medication was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers of the study didn't discover any connection between the use of early medications and congenital anomalies like facial deformities or club feet. The findings are in line with previous studies showing the presence of a small, but significant increase in the risk of heart malformations among women who started taking ADHD medications prior to the birth of their child. The risk increased in the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who used ADHD medication in the first trimester of pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby who required breathing assistance during birth. However, the authors of the study were not able to eliminate selection bias by limiting the study to women who didn't have any other medical issues that could have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of physicians who encounter pregnant women. They recommend that, while discussing the benefits and risks is important but the decision to stop or keep medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is a possibility to consider, it is not recommended due to the high rate depression and other mental disorders for women who are pregnant or who have recently given birth. Further, the research suggests that women who choose to stop taking their medication for inattentive adhd and anxiety are more likely to have difficulties adjusting to life without them after the baby's arrival.

Nursing

It can be overwhelming becoming a mother. Women suffering from ADHD may face a lot of challenges when they have to manage their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to new routines. Therefore, many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs pass through breast milk in very small amounts, so the risk to the infant who is breastfeeding is low. The rate of exposure to medication can vary depending upon the dosage the medication is administered, its frequency and the time of day. Additionally, different medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact on the health of a newborn isn't completely comprehended.

Due to the absence of research, some physicians may be inclined to discontinue stimulant medication during the course of pregnancy. This is a difficult choice for the patient, who must balance the benefit of continuing her medication against the possible dangers to the embryo. As long as more information is available, GPs can inquire about pregnant patients whether they have an background of ADHD or if they are planning to take medication in the perinatal period.

A increasing number of studies have revealed that the majority of women are able to safely continue to take their ADHD medication while they are pregnant and nursing. This has led to an increasing number of patients choose to do so and in consultation with their physician, they have found that the benefits of continuing their current medication outweigh any risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their physician and discuss the pros and cons of continued treatment, including non stimulant adhd medication uk-pharmacological strategies. Psychoeducation is also required to help women with ADHD understand their symptoms and the root cause, learn about available treatment options and reinforce existing strategies for coping. This should be a multidisciplinary process with the GPs, obstetricians, and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.

  • Share

Reviews